Literature DB >> 15342114

Evidence for differences in the metabolism of saxitoxin and C1+2 toxins in the freshwater cyanobacterium Cylindrospermopsis raciborskii T3.

Francesco Pomati1, Michelle C Moffitt, Rosalia Cavaliere, Brett A Neilan.   

Abstract

The activity of paralytic shellfish poisoning (PSP) toxins biosynthetic enzymes was assayed in the cyanobacterium Cylindrospermopsis raciborskii T3 after inhibiting protein synthesis with chloramphenicol (CAM). The production of C1+2 and saxitoxin (STX) was sensitive to CAM with STX levels decreasing by 70% after 24-h exposure to the antibiotic. PSP toxin production was strongly promoted by arginine supplementation, with a maximum 476% increase in intracellular STX concentrations after 24-h exposure to 10 mM of the amino acid. However, arginine had no stimulating effect on PSP toxin levels if supplemented in combination with CAM at 10 microg l(-1). Addition of agmatine and proline to C. raciborskii T3 cultures in the presence of 10 microg l(-1) CAM increased C1+2 toxins levels, while having a negative or no effect on STX accumulation. In vitro, PSP toxin levels increased naturally in cyanobacterial extracts, with CAM and arginine having no influence on either C1+2 or STX synthesis. The evidence presented in this study suggests a possible difference between the metabolism of STX and the C1+2 toxins and indicated a high turnover rate of STX biosynthetic enzymes in C. raciborskii T3.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342114     DOI: 10.1016/j.bbagen.2004.05.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Detection of saxitoxin-producing cyanobacteria and Anabaena circinalis in environmental water blooms by quantitative PCR.

Authors:  Jamal Al-Tebrineh; Troco Kaan Mihali; Francesco Pomati; Brett A Neilan
Journal:  Appl Environ Microbiol       Date:  2010-10-08       Impact factor: 4.792

Review 2.  Neurotoxic alkaloids: saxitoxin and its analogs.

Authors:  Maria Wiese; Paul M D'Agostino; Troco K Mihali; Michelle C Moffitt; Brett A Neilan
Journal:  Mar Drugs       Date:  2010-07-20       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.